IQVIA Holdings Inc. IQV
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-04T06:39:59.149Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-04T00:00:00.002736367Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-04T06:33:03.308638+00:00
IQVIA Holdings Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 284.53 | 41.5% | 9.3% | 241.88 | 50.0% | 9.1% |
| 25Δ | 280.30 | 42.1% | 8.0% | 247.21 | 46.3% | 7.4% |
| 30Δ | 276.90 | 42.5% | 7.1% | 251.56 | 43.8% | 6.0% |
| 35Δ | 273.57 | 42.8% | 6.2% | 254.82 | 42.8% | 5.2% |
| 40Δ | 270.23 | 43.1% | 5.4% | 258.08 | 41.8% | 4.4% |
| 45Δ | 267.20 | 42.9% | 4.7% | 261.19 | 41.2% | 3.7% |
| 50Δ | 264.19 | 42.6% | 4.0% | 264.10 | 41.3% | 3.2% |
| 55Δ | 261.19 | 42.3% | 3.4% | 267.00 | 41.4% | 2.7% |
| 60Δ | 258.05 | 42.6% | 2.9% | 269.91 | 41.5% | 2.2% |
| 65Δ | 254.84 | 43.1% | 2.4% | 273.30 | 41.6% | 1.8% |
| 70Δ | 251.63 | 43.7% | 2.0% | 276.71 | 41.7% | 1.4% |
| 75Δ | 247.97 | 44.1% | 1.6% | 280.19 | 41.9% | 1.1% |
| 80Δ | 243.86 | 44.5% | 1.3% | 285.77 | 43.7% | 0.8% |
20Δ
- Pseudo strike
- 284.53
- IV
- 41.5%
- B/E move
- 9.3%
- Pseudo strike
- 241.88
- IV
- 50.0%
- B/E move
- 9.1%
25Δ
- Pseudo strike
- 280.30
- IV
- 42.1%
- B/E move
- 8.0%
- Pseudo strike
- 247.21
- IV
- 46.3%
- B/E move
- 7.4%
30Δ
- Pseudo strike
- 276.90
- IV
- 42.5%
- B/E move
- 7.1%
- Pseudo strike
- 251.56
- IV
- 43.8%
- B/E move
- 6.0%
35Δ
- Pseudo strike
- 273.57
- IV
- 42.8%
- B/E move
- 6.2%
- Pseudo strike
- 254.82
- IV
- 42.8%
- B/E move
- 5.2%
40Δ
- Pseudo strike
- 270.23
- IV
- 43.1%
- B/E move
- 5.4%
- Pseudo strike
- 258.08
- IV
- 41.8%
- B/E move
- 4.4%
45Δ
- Pseudo strike
- 267.20
- IV
- 42.9%
- B/E move
- 4.7%
- Pseudo strike
- 261.19
- IV
- 41.2%
- B/E move
- 3.7%
50Δ
- Pseudo strike
- 264.19
- IV
- 42.6%
- B/E move
- 4.0%
- Pseudo strike
- 264.10
- IV
- 41.3%
- B/E move
- 3.2%
55Δ
- Pseudo strike
- 261.19
- IV
- 42.3%
- B/E move
- 3.4%
- Pseudo strike
- 267.00
- IV
- 41.4%
- B/E move
- 2.7%
60Δ
- Pseudo strike
- 258.05
- IV
- 42.6%
- B/E move
- 2.9%
- Pseudo strike
- 269.91
- IV
- 41.5%
- B/E move
- 2.2%
65Δ
- Pseudo strike
- 254.84
- IV
- 43.1%
- B/E move
- 2.4%
- Pseudo strike
- 273.30
- IV
- 41.6%
- B/E move
- 1.8%
70Δ
- Pseudo strike
- 251.63
- IV
- 43.7%
- B/E move
- 2.0%
- Pseudo strike
- 276.71
- IV
- 41.7%
- B/E move
- 1.4%
75Δ
- Pseudo strike
- 247.97
- IV
- 44.1%
- B/E move
- 1.6%
- Pseudo strike
- 280.19
- IV
- 41.9%
- B/E move
- 1.1%
80Δ
- Pseudo strike
- 243.86
- IV
- 44.5%
- B/E move
- 1.3%
- Pseudo strike
- 285.77
- IV
- 43.7%
- B/E move
- 0.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 39.09% | |
| 37.60% | |
| 37.91% | |
| 36.51% | |
| 36.73% | |
| 37.00% | |
| 34.82% | |
| 36.22% | |
| 36.77% | |
| 36.15% | |
| 36.65% | |
| 36.23% | |
| 36.34% | |
| 35.74% | |
| 34.78% | |
| 34.52% | |
| 35.58% | |
| 35.24% | |
| 34.80% | |
| 35.90% | |
| 37.28% | |
| 38.00% | |
| 37.19% | |
| 37.20% | |
| 39.17% | |
| 39.54% | |
| 38.85% | |
| 38.19% | |
| 36.61% | |
| 37.56% | |
| 37.55% | |
| 38.40% | |
| 38.14% | |
| 37.68% | |
| 37.59% | |
| 38.04% | |
| 38.04% | |
| 37.53% | |
| 37.61% | |
| 37.64% | |
| 39.10% | |
| 39.16% | |
| 39.42% | |
| 39.24% | |
| 39.78% | |
| 40.76% | |
| 40.83% | |
| 42.11% | |
| 41.52% | |
| 41.79% | |
| 42.47% | |
| 42.82% | |
| 43.23% | |
| 42.66% | |
| 43.40% | |
| 35.93% | |
| 36.46% | |
| 35.66% | |
| 38.42% |
Diagnostics & Research
LH
Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest…
More →MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in…
More →MTD
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory,…
More →MYGN
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The…
More →NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
More →NTRA
Description unavailable
More →